- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 4.19 Warrant to Purchase Stock Agreement
- 10.27 Exclusive Option Agreement
- 10.53 Employment Agreement
- 23.1 Consent of KPMG LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ARCA biopharma, Inc.:
We consent to the incorporation by reference in the registration statements (Nos. 333-148288, 333-131392, 333-128316, 333-126591, 333-118821, 333-112209, 333-106873, 333-103257, 333-90458, and 333-70134) on Form S-3 and the registration statements (Nos. 333-161485, 333-146078, 333-134981, 333-126590, 333-115747, 333-108563, 333-103055, 333-101276, 333-96313, 333-91471, 333-68172, 333-68170, 333-53089, 333-53087, 333-41663, 333-39194, 333-08978, and 333-154839) on Form S-8 of ARCA biopharma, Inc. of our report dated March 4, 2010, with respect to the consolidated balance sheets of ARCA biopharma, Inc. as of December 31, 2009 and 2008, and the related consolidated statements of operations, preferred stock and stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2009, and for the period from December 17, 2001 (inception) to December 31, 2009, which report appears in the December 31, 2009 annual report on Form 10-K of ARCA biopharma, Inc.
/s/ KPMG LLP
Boulder, Colorado
March 4, 2010